References
- Genazzani AR, Gambacciani M, Simoncini T, Schneider H. Hormone replacement therapy in climacteric and aging brain. Climacteric 2003;6:188–203
- Kerchner A, Lester W, Stuart S, Dokra A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009;91:207–12
- Studd J, Panay N. Chronic fatigue syndrome. Lancet 1996;348:1384
- Cunningham J, Yonkers KA, O'Brien S, Eriksson E. Update on research and treatment of premenstrual dysphoric disorder. Harv Rev Psychiatry 2009;17:120–37
- Huo L, Straub R, Roca C, et al Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 2007;62:925–33
- Studd J, Panay N. Hormones and depression in women. Climacteric 2004;7:338–46
- Weickert CS, Miranda-Angulo AL, Wong J, et al Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 2008;17:2293–309
- Kulkarni J, de Castella A, Fitzgerald P, et al Estrogen in severe mental illness. A potential new treatment approach. Arch Gen Psychiatry 2008;65:955–60
- Kulkarni J. Oestrogen – a new treatment approach for schizophrenia? Med J Aust 2009;190(4 Suppl):S37–8